Equities research analysts expect that Mettler-Toledo International Inc. (NYSE:MTD) will announce $736.34 million in sales for the current fiscal quarter, according to Zacks Investment Research. Five analysts have provided estimates for Mettler-Toledo International’s earnings, with the highest sales estimate coming in at $748.00 million and the lowest estimate coming in at $732.48 million. Mettler-Toledo International reported sales of $722.00 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 2%. The business is expected to report its next quarterly earnings results on Thursday, July 25th.
On average, analysts expect that Mettler-Toledo International will report full year sales of $3.04 billion for the current financial year, with estimates ranging from $3.02 billion to $3.07 billion. For the next financial year, analysts forecast that the company will post sales of $3.20 billion, with estimates ranging from $3.17 billion to $3.22 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research firms that cover Mettler-Toledo International.
Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, May 9th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $4.06 by $0.04. The business had revenue of $679.50 million for the quarter, compared to analyst estimates of $673.55 million. Mettler-Toledo International had a net margin of 17.98% and a return on equity of 95.67%. Mettler-Toledo International’s revenue was up 2.8% on a year-over-year basis. During the same period in the prior year, the firm earned $3.74 earnings per share.
In related news, insider Oliver A. Filliol sold 34,100 shares of the stock in a transaction dated Friday, February 15th. The shares were sold at an average price of $666.30, for a total transaction of $22,720,830.00. Following the completion of the transaction, the insider now owns 33,279 shares in the company, valued at $22,173,797.70. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Robert F. Spoerry sold 27,000 shares of the stock in a transaction dated Tuesday, February 19th. The shares were sold at an average price of $670.74, for a total transaction of $18,109,980.00. Following the transaction, the director now owns 7,894 shares of the company’s stock, valued at approximately $5,294,821.56. The disclosure for this sale can be found here. In the last quarter, insiders sold 99,100 shares of company stock valued at $66,456,660. 3.50% of the stock is currently owned by corporate insiders.
Institutional investors and hedge funds have recently bought and sold shares of the stock. CIBC Private Wealth Group LLC increased its stake in Mettler-Toledo International by 3.3% in the 1st quarter. CIBC Private Wealth Group LLC now owns 470 shares of the medical instruments supplier’s stock valued at $340,000 after buying an additional 15 shares during the last quarter. Quadrant Private Wealth Management LLC increased its position in Mettler-Toledo International by 4.5% during the 4th quarter. Quadrant Private Wealth Management LLC now owns 399 shares of the medical instruments supplier’s stock worth $226,000 after purchasing an additional 17 shares in the last quarter. Thrivent Financial for Lutherans grew its holdings in Mettler-Toledo International by 1.7% during the 4th quarter. Thrivent Financial for Lutherans now owns 1,108 shares of the medical instruments supplier’s stock worth $627,000 after acquiring an additional 19 shares during the last quarter. Commonwealth Bank of Australia grew its holdings in Mettler-Toledo International by 9.1% during the 1st quarter. Commonwealth Bank of Australia now owns 253 shares of the medical instruments supplier’s stock worth $181,000 after acquiring an additional 21 shares during the last quarter. Finally, Eukles Asset Management grew its holdings in Mettler-Toledo International by 2.8% during the 1st quarter. Eukles Asset Management now owns 795 shares of the medical instruments supplier’s stock worth $575,000 after acquiring an additional 22 shares during the last quarter. Institutional investors own 96.04% of the company’s stock.
NYSE MTD traded up $23.56 on Monday, hitting $742.70. 15,978 shares of the company were exchanged, compared to its average volume of 140,676. The firm has a market cap of $17.41 billion, a PE ratio of 36.56, a P/E/G ratio of 2.26 and a beta of 1.33. Mettler-Toledo International has a 12 month low of $500.74 and a 12 month high of $762.90. The company has a quick ratio of 0.97, a current ratio of 1.37 and a debt-to-equity ratio of 1.80.
About Mettler-Toledo International
Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications.
Featured Article: What is the Beige Book?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.